Light-excited flexible and self-healing luminescent polymers have attracted extensive attention for developing advanced color-emitting films. Luminophores on the base of lanthanide(III)-incorporating polysiloxanes exhibit a high photoresponse and can be applied for controlled color lighting in flexible device applications. We present red-, green-, and blue-emitting Eu 3+ , Tb 3+ , and Tm 3+ -bipyridinedicarboxamide-co-polydimethylsiloxanes (Ln-Bipy-PDMS) produced with a two-step procedure of polycondensation and complexation. Bipyridinic ligands provide formation of coordinatively saturated complexes of lanthanide ions and strong photoluminescence (PL) in the case of Eu 3+ and Tb 3+ . The thin Ln-Bipy-PDMS films are studied as ultraviolet-light converters, which can be mechanically stacked one above another to achieve the desired color. We demonstrate that these stacks can have intense PL in the spectral range from green to yellow and red. Due to the structural features, Ln-Bipy-PDMS also demonstrate a relatively high tensile (approximately 1.5 MPa) and elongation at break (approximately 185%) and non-autonomous self-healing on heating. The self-healing properties of Ln-Bipy-PDMS enable the stacking of films into monoliths with the required color of PL. Such systems do not require any synthesis stages, and a one-healed monolith film possesses two luminescence colors.
The properties of n‐GaP/p‐Si interface as well as their influence on solar cell performance are studied for GaP layers grown by low‐temperature (380 °C) plasma‐enhanced atomic layer deposition (PE‐ALD). The influence of different plasma treatments and RF power values are explored. The increase of RF power leads to a growth transition from amorphous (a‐GaP) to microcrystalline GaP (μc‐GaP) with either amorphous‐GaP/Si or epitaxial‐GaP/Si interface, respectively. However, when continuous hydrogen plasma is used the amorphous‐GaP/Si interface exhibits better photovoltaic performance compared to the epitaxial one. Values of open circuit voltage, Voc = 0.45–0.55 V and internal quantum efficiencies, IQE > 0.9 are obtained for amorphous‐GaP/Si interfaces compared to Voc = 0.25–0.35 V and IQE < 0.45 for epitaxial‐GaP/Si interfaces. According to admittance spectroscopy and TEM studies the near‐surface (30–50 nm) area of the Si substrate is damaged during growth with high RF power of hydrogen plasma. A hole trap at the level of EV + (0.33 ± 0.02) eV is detected by admittance spectroscopy in this damaged Si area. The damage of Si is not observed by TEM when the deposition of the structures with epitaxial‐GaP/Si interface is realized by a modified process without hydrogen plasma indicating that the damage of the near‐surface area of Si is related to hydrogen plasma interaction.
An approach for epitaxial growth of GaP layers on Si substrates at low temperature (380°C) by plasma-enhanced atomic layer deposition (PEALD) is explored. A significant improvement of the crystalline properties of the GaP layers is obtained using additional in-situ Ar plasma treatment. The epitaxial growth for the first 20-30 nm of GaP on Si is demonstrated from transmission electron microscopy. Moreover, the use of in-situ Ar plasma treatment during the PEALD process allows one to increase the growth rate per cycle from 0.9±0.1 Å/cycle to 1.9±0.1 Å/cycle and reduce the RMS roughness from 3.76 nm to 1.88 nm. The effect of Ar plasma treatment on the electronic properties of the GaP/Si interface is studied by deep level transient spectroscopy (DLTS). A defect level at (0.33±0.03) eV below the conduction band is observed in the subsurface layer of Si for the GaP/Si structure grown under Ar plasma treatment. However, the defect response observed by DLTS vanishes after rapid thermal annealing at 500 ºC in nitrogen ambient.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.